Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

Condition:   Epithelioid Hemangioendothelioma Interventions:   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration;   Drug: Trametinib Sponsor:   National Cancer Institute (NCI) Recruiting - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials